Recently, open science has been making major strides in the news. Sure, people have been clamoring for full disclosure and availability of journal…

Computational drug discovery has reduced the time and money required for research and development while increasing the potential number of drug leads in…

This is the second in a three-part series by Dr. Heather Buschman on Big Data in the pharmaceutical and biotechnology industries. Check out…

With the Big Data Science Innovation Summit 1 happening next month here in San Diego, we invited Dr. Heather Buschman to share current views on Big…

Recently, Oxbridge Biotech Roundtable (OBR) interviewed Assay Depot’s Kevin Lustig about how his career decisions and approach to research shaped his view of…